Simon ellison

Networked cell & gene therapy catalyst, focusing on supply chain. Cell & Gene Therapy Service Director - World Courier . Views expressed are my own.

[Simon ellison @Simon_H_Ellison]

MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner https://t.co/ItWz0ZKEDN

[Simon ellison @Simon_H_Ellison]

Unlawful Stem Cell Products Continue to Harm People as FDA Deadline Looms https://t.co/vJw6Ieab2v

[Simon ellison @Simon_H_Ellison]

Mesoblast Submits Completed Biologics License Application for Ryonciltm to US FDA https://t.co/2dSzDmGAqj

[Simon ellison @Simon_H_Ellison]

Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315M, Creating an Industry-Leading Cell & Gene Therapy Platform https://t.co/SoTAMYYuLy

[Simon ellison @Simon_H_Ellison]

Beam Therapeutics Announces Pricing of $180M Initial Public Offering https://t.co/QUYbo2AFJ6

[Simon ellison @Simon_H_Ellison]

Sonoma Biotherapeutics Launches With $40M in Series A Funding to Advance Regulatory T Cell Therapy in Autoimmune and Degenerative Diseases https://t.co/nY04Y3vVKv

[Simon ellison @Simon_H_Ellison]

Catalent Buys Cell Therapy Company MaSTherCell Global, For $315M https://t.co/179rTd7rjM

[Simon ellison @Simon_H_Ellison]

Congratulation Matthew https://t.co/MUIc00RMe2

[World Courier @Worldcourier]

With the emergence of #cellandgenetherapy, manufacturers need partners with the expertise to develop the right plan to meet their immediate needs and help them scale smoothly. @Simon_H_Ellison shares his insight with @FiercePharma #advancedtherapies

[Simon ellison @Simon_H_Ellison]

Iovance and Cellectis Working together https://t.co/cGNLVoWJcK

[CCRM @CCRM_ca]

Friday, Jan. 10 is the last day to register for this free in-person event or webinar on #SupplyChain and #logistics
in #CGT featuring @Simon_H_Ellison Jacqueline Barry, Greg Crescenzi, Anuj Singla, Donna Wall and @MichaelMay5 Register now https://t.co/49We6hruEp @CellCAN_Network

[Cell and Gene Therapy Catapult @CGTCatapult]

"The UK’s Cell and Gene Therapy Catapult has played a significant role in building the strong #advancedtherapy ecosystem in the UK – the largest outside the USA". Keith Thompson, CEO talks to @medicine_maker in this week's #manufacturing feature: https://t.co/TZ7ZxLKOxZ

[Simon ellison @Simon_H_Ellison]

Novartis' AveXis opens Zolgensma plant in Colorado with 350 employees https://t.co/Uhg7OgELtd

[Jacob Plieth @JacobPlieth]

Quite the exposé about dodgy stem cell clinics on Radio 4 last night https://t.co/dlTPCoKUje cc @cells_nnm

[BioIndustry Association (BIA) @BIA_UK]

The Advanced Therapy Treatment Centre (ATTC) network was set up 18 months ago in response to the challenge faced by the UK to bring cell and gene therapies into routine medical practice.

See the impact of the ATTC Network after 18 months of operation👇

[Cell and Gene Therapy Catapult @CGTCatapult]

After 18 months of operation, the ATTC network continues to work with industry partners & the public sector across the UK to develop necessary processes & infrastructure at scale as more #innovative products move from #clinicaltrial to market. Learn more: https://t.co/35SrTROH8q

[Cell and Gene Therapy Catapult @CGTCatapult]

With 98% of #advancedtherapy companies looking to increase their headcount in the next five years, there is accelerated demand for specialist skills in the UK #celltherapy & #genetherapy industry. Skills Demand report findings covered by @BioPharmaReport https://t.co/3MLAND4NUJ

[Simon ellison @Simon_H_Ellison]

To meet market demand we now have storage capability in Istanbul https://t.co/25UM3AbUOw

[Simon ellison @Simon_H_Ellison]

China convicts 3 researchers involved in gene-edited babies https://t.co/L0ERuhmQZH

[Simon ellison @Simon_H_Ellison]

Japanese pharma company Astellas has inked a deal to buy out US-based biotech Xyphos, to bolster its immuno-oncology pipeline. https://t.co/MvdJ9HzPzj